

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal epithelial cell development (GO:0060576) | 7.09837208 |
| 2 | piRNA metabolic process (GO:0034587) | 6.22148470 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.75500449 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.75500449 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.75500449 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.75500449 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.75500449 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.75500449 |
| 9 | post-embryonic morphogenesis (GO:0009886) | 5.65387428 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.36667870 |
| 11 | negative regulation of cell killing (GO:0031342) | 5.36667870 |
| 12 | folic acid-containing compound biosynthetic process (GO:0009396) | 5.11152825 |
| 13 | organ formation (GO:0048645) | 4.65434697 |
| 14 | maturation of SSU-rRNA (GO:0030490) | 4.43615951 |
| 15 | iron ion import (GO:0097286) | 4.38671081 |
| 16 | regulation of translational termination (GO:0006449) | 4.23187709 |
| 17 | chromatin assembly (GO:0031497) | 4.11207423 |
| 18 | nuclear pore organization (GO:0006999) | 4.08357737 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.01680642 |
| 20 | regulation of meiosis I (GO:0060631) | 3.95533767 |
| 21 | maternal placenta development (GO:0001893) | 3.93580597 |
| 22 | DNA methylation involved in gamete generation (GO:0043046) | 3.73726253 |
| 23 | ribosomal large subunit biogenesis (GO:0042273) | 3.68677543 |
| 24 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.66116441 |
| 25 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.66116441 |
| 26 | negative regulation of monooxygenase activity (GO:0032769) | 3.65337019 |
| 27 | heterochromatin organization (GO:0070828) | 3.65122146 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.60652423 |
| 29 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.60078017 |
| 30 | RNA stabilization (GO:0043489) | 3.58622510 |
| 31 | mRNA stabilization (GO:0048255) | 3.58622510 |
| 32 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.54553732 |
| 33 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.44986723 |
| 34 | IMP biosynthetic process (GO:0006188) | 3.42345694 |
| 35 | microglial cell activation (GO:0001774) | 3.39747402 |
| 36 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.36716666 |
| 37 | G-protein coupled receptor internalization (GO:0002031) | 3.35515890 |
| 38 | postsynaptic membrane organization (GO:0001941) | 3.35375421 |
| 39 | mitotic nuclear envelope disassembly (GO:0007077) | 3.32970216 |
| 40 | positive regulation of metanephros development (GO:0072216) | 3.31567570 |
| 41 | I-kappaB phosphorylation (GO:0007252) | 3.29843376 |
| 42 | endothelium development (GO:0003158) | 3.26726007 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.24727993 |
| 44 | ribosome assembly (GO:0042255) | 3.24625560 |
| 45 | response to host immune response (GO:0052572) | 3.24155375 |
| 46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.24155375 |
| 47 | DNA unwinding involved in DNA replication (GO:0006268) | 3.23027940 |
| 48 | membrane disassembly (GO:0030397) | 3.22919562 |
| 49 | nuclear envelope disassembly (GO:0051081) | 3.22919562 |
| 50 | negative regulation of histone acetylation (GO:0035067) | 3.22326935 |
| 51 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.20280704 |
| 52 | IMP metabolic process (GO:0046040) | 3.16678660 |
| 53 | cellular hyperosmotic response (GO:0071474) | 3.13229765 |
| 54 | histone H3-K36 demethylation (GO:0070544) | 3.08172524 |
| 55 | gene silencing by RNA (GO:0031047) | 3.05183079 |
| 56 | bone resorption (GO:0045453) | 3.03002659 |
| 57 | L-serine metabolic process (GO:0006563) | 3.02467256 |
| 58 | N-acetylneuraminate metabolic process (GO:0006054) | 3.01590860 |
| 59 | apoptotic process involved in morphogenesis (GO:0060561) | 2.95311308 |
| 60 | sphingosine metabolic process (GO:0006670) | 2.95011612 |
| 61 | positive regulation of catecholamine secretion (GO:0033605) | 2.94462035 |
| 62 | nucleobase biosynthetic process (GO:0046112) | 2.93358905 |
| 63 | regulation of DNA damage checkpoint (GO:2000001) | 2.93303734 |
| 64 | ribosomal small subunit biogenesis (GO:0042274) | 2.91470758 |
| 65 | rRNA processing (GO:0006364) | 2.90368697 |
| 66 | regulation of histone H3-K9 methylation (GO:0051570) | 2.89055474 |
| 67 | folic acid metabolic process (GO:0046655) | 2.87935249 |
| 68 | regulation of translational fidelity (GO:0006450) | 2.85633169 |
| 69 | myeloid dendritic cell differentiation (GO:0043011) | 2.82977638 |
| 70 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.82976164 |
| 71 | nuclear pore complex assembly (GO:0051292) | 2.82083368 |
| 72 | rRNA metabolic process (GO:0016072) | 2.81628187 |
| 73 | pre-miRNA processing (GO:0031054) | 2.81348773 |
| 74 | lipopolysaccharide metabolic process (GO:0008653) | 2.79602650 |
| 75 | peptidyl-arginine methylation (GO:0018216) | 2.78753504 |
| 76 | peptidyl-arginine N-methylation (GO:0035246) | 2.78753504 |
| 77 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.78522538 |
| 78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.77644677 |
| 79 | positive regulation of vasculogenesis (GO:2001214) | 2.77169381 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.76407550 |
| 81 | response to host (GO:0075136) | 2.76407550 |
| 82 | response to host defenses (GO:0052200) | 2.76407550 |
| 83 | gamma-aminobutyric acid transport (GO:0015812) | 2.74512880 |
| 84 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.74133463 |
| 85 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.73162362 |
| 86 | mesenchymal to epithelial transition (GO:0060231) | 2.71255042 |
| 87 | oocyte development (GO:0048599) | 2.69804155 |
| 88 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.68884772 |
| 89 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.68884772 |
| 90 | positive regulation of male gonad development (GO:2000020) | 2.68110361 |
| 91 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.68029791 |
| 92 | ncRNA 3-end processing (GO:0043628) | 2.67220104 |
| 93 | regulation of integrin activation (GO:0033623) | 2.62832710 |
| 94 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.61334042 |
| 95 | nucleosome assembly (GO:0006334) | 2.61008039 |
| 96 | germ cell migration (GO:0008354) | 2.60670292 |
| 97 | auditory receptor cell differentiation (GO:0042491) | 2.60668896 |
| 98 | regulation of mRNA stability (GO:0043488) | 2.60132981 |
| 99 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.57848579 |
| 100 | spleen development (GO:0048536) | 2.57813372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.63506621 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.27715411 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.33052823 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.02411899 |
| 5 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.93725628 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.87670369 |
| 7 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.84714611 |
| 8 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.80812964 |
| 9 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.66704295 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.58751776 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.57332132 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.45841426 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.12727577 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.03611995 |
| 15 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.02057820 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 11.5072059 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.93032650 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.92489147 |
| 19 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.91488834 |
| 20 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.82680942 |
| 21 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.73010392 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.71057671 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.67667851 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.66575949 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.65917210 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.65144716 |
| 27 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.64659151 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.62767806 |
| 29 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.56088565 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53709125 |
| 31 | P68_20966046_ChIP-Seq_HELA_Human | 1.49646563 |
| 32 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.49201707 |
| 33 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.48253171 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43946059 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.42076278 |
| 36 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.41225660 |
| 37 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.38921458 |
| 38 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.35517099 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.35497675 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34461438 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32270601 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30284542 |
| 43 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.27517469 |
| 44 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27379915 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26807521 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.24331205 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20427892 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.20207601 |
| 49 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.19998832 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.19498860 |
| 51 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19386190 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19221612 |
| 53 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.18180415 |
| 54 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.16594268 |
| 55 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.16088340 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15938630 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.15710440 |
| 58 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15457382 |
| 59 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.15295691 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13935058 |
| 61 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.12710955 |
| 62 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04699510 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03075342 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03012949 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01575074 |
| 66 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.99052510 |
| 67 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98763190 |
| 68 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97716996 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97603954 |
| 70 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97288213 |
| 71 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94019269 |
| 72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93952080 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93887762 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91895438 |
| 75 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91556561 |
| 76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90866713 |
| 77 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.90830845 |
| 78 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90669216 |
| 79 | SA1_27219007_Chip-Seq_Bcells_Human | 0.89484345 |
| 80 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88271060 |
| 81 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.87018575 |
| 82 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.86398194 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83954139 |
| 84 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.83185863 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81674820 |
| 86 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.81547429 |
| 87 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.81105525 |
| 88 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.81013886 |
| 89 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.80224043 |
| 90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.80200251 |
| 91 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80071165 |
| 92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78418529 |
| 93 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.77898917 |
| 94 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76866612 |
| 95 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.76235325 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75313152 |
| 97 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.74453834 |
| 98 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.74325763 |
| 99 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72244054 |
| 100 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.71888929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.32419274 |
| 2 | MP0003195_calcinosis | 2.98398539 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 2.97218253 |
| 4 | MP0009333_abnormal_splenocyte_physiolog | 2.61672275 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.52251308 |
| 6 | MP0000604_amyloidosis | 2.22255642 |
| 7 | MP0004185_abnormal_adipocyte_glucose | 2.17277852 |
| 8 | MP0001346_abnormal_lacrimal_gland | 2.02378881 |
| 9 | MP0003283_abnormal_digestive_organ | 10.1934229 |
| 10 | MP0001188_hyperpigmentation | 1.99883448 |
| 11 | MP0004134_abnormal_chest_morphology | 1.93629451 |
| 12 | MP0005058_abnormal_lysosome_morphology | 1.87124610 |
| 13 | MP0005451_abnormal_body_composition | 1.86495125 |
| 14 | MP0001661_extended_life_span | 1.86310922 |
| 15 | MP0004808_abnormal_hematopoietic_stem | 1.84810352 |
| 16 | MP0008995_early_reproductive_senescence | 1.79964512 |
| 17 | MP0003111_abnormal_nucleus_morphology | 1.75646766 |
| 18 | MP0000490_abnormal_crypts_of | 1.71478685 |
| 19 | MP0010307_abnormal_tumor_latency | 1.68669821 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 1.65874468 |
| 21 | MP0003436_decreased_susceptibility_to | 1.65475706 |
| 22 | MP0000015_abnormal_ear_pigmentation | 1.64424580 |
| 23 | MP0000383_abnormal_hair_follicle | 1.63621045 |
| 24 | MP0005174_abnormal_tail_pigmentation | 1.53851381 |
| 25 | MP0009840_abnormal_foam_cell | 1.53573691 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.46654243 |
| 27 | MP0002751_abnormal_autonomic_nervous | 1.46171675 |
| 28 | MP0003866_abnormal_defecation | 1.40160875 |
| 29 | MP0008877_abnormal_DNA_methylation | 1.40119630 |
| 30 | MP0005187_abnormal_penis_morphology | 1.38030805 |
| 31 | MP0003786_premature_aging | 1.37900404 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.37655979 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.33901121 |
| 34 | MP0003119_abnormal_digestive_system | 1.30317030 |
| 35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.29837646 |
| 36 | MP0000427_abnormal_hair_cycle | 1.25168474 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.25058092 |
| 38 | MP0010094_abnormal_chromosome_stability | 1.24215539 |
| 39 | MP0006082_CNS_inflammation | 1.19893844 |
| 40 | MP0004742_abnormal_vestibular_system | 1.18486998 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.16994559 |
| 42 | MP0004859_abnormal_synaptic_plasticity | 1.15495069 |
| 43 | MP0001800_abnormal_humoral_immune | 1.15471195 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.13530972 |
| 45 | MP0003879_abnormal_hair_cell | 1.12153733 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.11264168 |
| 47 | MP0002254_reproductive_system_inflammat | 1.09859859 |
| 48 | MP0000462_abnormal_digestive_system | 1.09745585 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.09681285 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.08004992 |
| 51 | MP0003693_abnormal_embryo_hatching | 1.06198711 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.05420170 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.03985550 |
| 54 | MP0002735_abnormal_chemical_nociception | 1.02899864 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.02151890 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.02055950 |
| 57 | MP0001145_abnormal_male_reproductive | 0.96624990 |
| 58 | MP0009785_altered_susceptibility_to | 0.96497952 |
| 59 | MP0002210_abnormal_sex_determination | 0.95170776 |
| 60 | MP0001790_abnormal_immune_system | 0.94243935 |
| 61 | MP0005387_immune_system_phenotype | 0.94243935 |
| 62 | MP0002723_abnormal_immune_serum | 0.93997665 |
| 63 | MP0002998_abnormal_bone_remodeling | 0.87571732 |
| 64 | MP0002405_respiratory_system_inflammati | 0.87461833 |
| 65 | MP0005381_digestive/alimentary_phenotyp | 0.87120595 |
| 66 | MP0000537_abnormal_urethra_morphology | 0.86326931 |
| 67 | MP0005464_abnormal_platelet_physiology | 0.82278062 |
| 68 | MP0009278_abnormal_bone_marrow | 0.82174766 |
| 69 | MP0002398_abnormal_bone_marrow | 0.79951783 |
| 70 | MP0003077_abnormal_cell_cycle | 0.79839653 |
| 71 | MP0001730_embryonic_growth_arrest | 0.79380516 |
| 72 | MP0000653_abnormal_sex_gland | 0.79197485 |
| 73 | MP0000350_abnormal_cell_proliferation | 0.78851822 |
| 74 | MP0004957_abnormal_blastocyst_morpholog | 0.78737994 |
| 75 | MP0002419_abnormal_innate_immunity | 0.78524051 |
| 76 | MP0000716_abnormal_immune_system | 0.76347942 |
| 77 | MP0008058_abnormal_DNA_repair | 0.76311979 |
| 78 | MP0001533_abnormal_skeleton_physiology | 0.76181780 |
| 79 | MP0002420_abnormal_adaptive_immunity | 0.75506889 |
| 80 | MP0001819_abnormal_immune_cell | 0.75474077 |
| 81 | MP0000343_altered_response_to | 0.72903206 |
| 82 | MP0010155_abnormal_intestine_physiology | 0.72191428 |
| 83 | MP0000647_abnormal_sebaceous_gland | 0.71793357 |
| 84 | MP0001727_abnormal_embryo_implantation | 0.71122528 |
| 85 | MP0002722_abnormal_immune_system | 0.70553964 |
| 86 | MP0001849_ear_inflammation | 0.70356990 |
| 87 | MP0005647_abnormal_sex_gland | 0.70110920 |
| 88 | MP0003315_abnormal_perineum_morphology | 0.69954121 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.69384796 |
| 90 | MP0003718_maternal_effect | 0.68642851 |
| 91 | MP0005025_abnormal_response_to | 0.68271060 |
| 92 | MP0002295_abnormal_pulmonary_circulatio | 0.68214217 |
| 93 | MP0001915_intracranial_hemorrhage | 0.68197271 |
| 94 | MP0003795_abnormal_bone_structure | 0.68197269 |
| 95 | MP0002429_abnormal_blood_cell | 0.66203739 |
| 96 | MP0005508_abnormal_skeleton_morphology | 0.64551754 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.62669851 |
| 98 | MP0000470_abnormal_stomach_morphology | 0.62643485 |
| 99 | MP0008770_decreased_survivor_rate | 0.61904391 |
| 100 | MP0002184_abnormal_innervation | 0.60584614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent frontal sinuses (HP:0002688) | 4.57668119 |
| 2 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 4.40690311 |
| 3 | Osteolytic defects of the hand bones (HP:0009699) | 4.40690311 |
| 4 | J-shaped sella turcica (HP:0002680) | 4.11777672 |
| 5 | Dysostosis multiplex (HP:0000943) | 4.03840377 |
| 6 | Abnormal vertebral ossification (HP:0100569) | 3.98489309 |
| 7 | Persistence of primary teeth (HP:0006335) | 3.96870591 |
| 8 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.91650440 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.78403069 |
| 10 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.69138643 |
| 11 | Upper limb muscle weakness (HP:0003484) | 3.61334570 |
| 12 | Acute lymphatic leukemia (HP:0006721) | 3.55556527 |
| 13 | Myocardial infarction (HP:0001658) | 3.40181813 |
| 14 | Achilles tendon contracture (HP:0001771) | 3.34023990 |
| 15 | Conjunctival telangiectasia (HP:0000524) | 3.33350226 |
| 16 | Mucopolysacchariduria (HP:0008155) | 3.27362763 |
| 17 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.27362763 |
| 18 | Spondylolisthesis (HP:0003302) | 3.20862499 |
| 19 | Annular pancreas (HP:0001734) | 3.19749853 |
| 20 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 3.15630911 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 3.09446416 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.06802942 |
| 23 | Abnormality of the Achilles tendon (HP:0005109) | 3.04397111 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.00138568 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.00138568 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.00138568 |
| 27 | Chromsome breakage (HP:0040012) | 2.96140021 |
| 28 | Distal lower limb amyotrophy (HP:0008944) | 2.96040566 |
| 29 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.92628569 |
| 30 | Cutaneous melanoma (HP:0012056) | 2.86187213 |
| 31 | Disproportionate short-trunk short stature (HP:0003521) | 2.79181089 |
| 32 | Reticulocytopenia (HP:0001896) | 2.77023622 |
| 33 | Abnormality of the umbilical cord (HP:0010881) | 2.71589385 |
| 34 | Abnormality of the frontal sinuses (HP:0002687) | 2.62813485 |
| 35 | Duplicated collecting system (HP:0000081) | 2.60782011 |
| 36 | Poikiloderma (HP:0001029) | 2.58829128 |
| 37 | Hypokinesia (HP:0002375) | 2.56499173 |
| 38 | Squamous cell carcinoma (HP:0002860) | 2.55367936 |
| 39 | Ridged nail (HP:0001807) | 2.49415846 |
| 40 | Pallor (HP:0000980) | 2.47643780 |
| 41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.45950301 |
| 42 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.45075953 |
| 43 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.43210975 |
| 44 | Lower limb amyotrophy (HP:0007210) | 2.40528675 |
| 45 | Hand muscle atrophy (HP:0009130) | 2.32709033 |
| 46 | Progressive muscle weakness (HP:0003323) | 2.29766734 |
| 47 | Sensory axonal neuropathy (HP:0003390) | 2.29739484 |
| 48 | Exercise-induced muscle cramps (HP:0003710) | 2.29472106 |
| 49 | Thoracic kyphosis (HP:0002942) | 2.27362128 |
| 50 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.26672087 |
| 51 | Single umbilical artery (HP:0001195) | 2.26672087 |
| 52 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.26672087 |
| 53 | Hypoventilation (HP:0002791) | 2.22645437 |
| 54 | Spinal cord compression (HP:0002176) | 2.17231959 |
| 55 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.17013296 |
| 56 | Bone pain (HP:0002653) | 2.16247546 |
| 57 | Abnormality of the lumbar spine (HP:0100712) | 2.15151571 |
| 58 | Prominent occiput (HP:0000269) | 2.14430379 |
| 59 | Abnormality of the thoracic spine (HP:0100711) | 2.11119258 |
| 60 | Hematochezia (HP:0002573) | 2.11095942 |
| 61 | Osteomyelitis (HP:0002754) | 2.02679112 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.01360787 |
| 63 | Obstructive lung disease (HP:0006536) | 2.01360787 |
| 64 | Diminished motivation (HP:0000745) | 1.99789425 |
| 65 | Mitral stenosis (HP:0001718) | 1.98758892 |
| 66 | Prolonged neonatal jaundice (HP:0006579) | 1.97975722 |
| 67 | Distal upper limb amyotrophy (HP:0007149) | 1.97559434 |
| 68 | Upper limb amyotrophy (HP:0009129) | 1.97559434 |
| 69 | Entropion (HP:0000621) | 1.97412416 |
| 70 | Stomatitis (HP:0010280) | 1.93544892 |
| 71 | Disinhibition (HP:0000734) | 1.93101484 |
| 72 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91268078 |
| 73 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91268078 |
| 74 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91268078 |
| 75 | Mediastinal lymphadenopathy (HP:0100721) | 1.89454205 |
| 76 | Apathy (HP:0000741) | 1.89264332 |
| 77 | Deformed sella turcica (HP:0002681) | 1.88195230 |
| 78 | Large earlobe (HP:0009748) | 1.85875741 |
| 79 | Abnormality of the renal collecting system (HP:0004742) | 1.84488066 |
| 80 | Premature rupture of membranes (HP:0001788) | 1.80600589 |
| 81 | Prominent nose (HP:0000448) | 1.78586508 |
| 82 | Overriding aorta (HP:0002623) | 1.74244408 |
| 83 | Clumsiness (HP:0002312) | 1.73781853 |
| 84 | Abnormality of reticulocytes (HP:0004312) | 1.71116369 |
| 85 | Basal cell carcinoma (HP:0002671) | 1.70344202 |
| 86 | Mucosal telangiectasiae (HP:0100579) | 1.70338735 |
| 87 | Neuronal loss in central nervous system (HP:0002529) | 1.69986010 |
| 88 | Hyperacusis (HP:0010780) | 1.69053289 |
| 89 | Vacuolated lymphocytes (HP:0001922) | 1.68551529 |
| 90 | Upper motor neuron abnormality (HP:0002127) | 1.66957778 |
| 91 | Rough bone trabeculation (HP:0100670) | 1.65673127 |
| 92 | Hypophosphatemic rickets (HP:0004912) | 1.65017916 |
| 93 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.62209961 |
| 94 | Metatarsus adductus (HP:0001840) | 1.59575499 |
| 95 | Scapular winging (HP:0003691) | 1.59016379 |
| 96 | Trismus (HP:0000211) | 1.58424315 |
| 97 | Delayed cranial suture closure (HP:0000270) | 1.56715776 |
| 98 | Muscle stiffness (HP:0003552) | 1.55367654 |
| 99 | Abnormal trabecular bone morphology (HP:0100671) | 1.55012655 |
| 100 | Patent foramen ovale (HP:0001655) | 1.54842027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.60560995 |
| 2 | FGR | 3.23472192 |
| 3 | PKN2 | 2.93135160 |
| 4 | PRKD3 | 2.76951405 |
| 5 | GRK1 | 2.64593378 |
| 6 | ZAP70 | 2.53546412 |
| 7 | CDK12 | 2.49230710 |
| 8 | MAP4K1 | 2.41948294 |
| 9 | TRIB3 | 2.30141468 |
| 10 | NME2 | 2.21112955 |
| 11 | CSNK1A1L | 2.20973913 |
| 12 | MAP2K3 | 2.01576913 |
| 13 | MAP3K11 | 1.93397220 |
| 14 | EEF2K | 1.91610972 |
| 15 | TESK2 | 1.80349783 |
| 16 | CAMK1G | 1.76494955 |
| 17 | ERN1 | 1.66508963 |
| 18 | STK4 | 1.66411634 |
| 19 | MAP3K10 | 1.60669020 |
| 20 | CAMK1D | 1.59333391 |
| 21 | RPS6KA5 | 1.58734600 |
| 22 | CDC7 | 1.56661538 |
| 23 | ALK | 1.56454201 |
| 24 | MAP3K3 | 1.51791150 |
| 25 | CSNK1G3 | 1.39700742 |
| 26 | MAP3K8 | 1.35247474 |
| 27 | IRAK3 | 1.34482189 |
| 28 | KDR | 1.32865895 |
| 29 | TAOK2 | 1.28526549 |
| 30 | FES | 1.28396553 |
| 31 | CAMKK1 | 1.21691242 |
| 32 | SCYL2 | 1.18369780 |
| 33 | MAP3K6 | 1.16387598 |
| 34 | PAK6 | 1.15485354 |
| 35 | PTK6 | 1.11821335 |
| 36 | BMX | 1.11525880 |
| 37 | PRPF4B | 1.10229264 |
| 38 | EIF2AK2 | 1.07306429 |
| 39 | STK16 | 1.07028371 |
| 40 | PAK2 | 1.06961884 |
| 41 | TLK1 | 1.05158417 |
| 42 | CDK7 | 1.00804610 |
| 43 | TYRO3 | 0.97319139 |
| 44 | CSNK1G2 | 0.93919540 |
| 45 | CSNK1G1 | 0.93075369 |
| 46 | JAK3 | 0.90437980 |
| 47 | MAP2K4 | 0.88938527 |
| 48 | MAP3K1 | 0.87684574 |
| 49 | SIK2 | 0.85099285 |
| 50 | IKBKB | 0.85067959 |
| 51 | MAP3K4 | 0.85018617 |
| 52 | LATS2 | 0.81297687 |
| 53 | NEK2 | 0.75798452 |
| 54 | PNCK | 0.73893053 |
| 55 | KSR2 | 0.72716846 |
| 56 | AURKA | 0.71669683 |
| 57 | LCK | 0.69271611 |
| 58 | CHUK | 0.68046224 |
| 59 | ITK | 0.67796882 |
| 60 | ICK | 0.65907420 |
| 61 | CHEK2 | 0.65637519 |
| 62 | CDK4 | 0.64909002 |
| 63 | HCK | 0.64509483 |
| 64 | CLK1 | 0.64377515 |
| 65 | PLK2 | 0.63782705 |
| 66 | TSSK6 | 0.63613404 |
| 67 | UHMK1 | 0.63045029 |
| 68 | PKN1 | 0.62164827 |
| 69 | FLT3 | 0.60552233 |
| 70 | MAP3K14 | 0.60050623 |
| 71 | MAP2K2 | 0.57243351 |
| 72 | DAPK3 | 0.53432765 |
| 73 | MAP3K5 | 0.53347078 |
| 74 | LYN | 0.53342347 |
| 75 | TAOK1 | 0.51579286 |
| 76 | AKT2 | 0.50542005 |
| 77 | EPHB1 | 0.49931878 |
| 78 | MINK1 | 0.48963304 |
| 79 | PASK | 0.48589485 |
| 80 | SYK | 0.48228430 |
| 81 | CSNK2A2 | 0.46740239 |
| 82 | GRK6 | 0.46544189 |
| 83 | EGFR | 0.44887887 |
| 84 | LATS1 | 0.44290549 |
| 85 | GSK3A | 0.43943543 |
| 86 | BUB1 | 0.43774974 |
| 87 | PTK2 | 0.42575188 |
| 88 | INSR | 0.42326673 |
| 89 | TESK1 | 0.41570434 |
| 90 | CSNK1D | 0.40579813 |
| 91 | CAMKK2 | 0.39249071 |
| 92 | DDR2 | 0.35686223 |
| 93 | CSNK1E | 0.35139428 |
| 94 | CSK | 0.34609953 |
| 95 | PDGFRB | 0.34198724 |
| 96 | ROCK2 | 0.34193510 |
| 97 | MARK1 | 0.33742074 |
| 98 | MTOR | 0.33619505 |
| 99 | PAK4 | 0.33193653 |
| 100 | TXK | 0.32888069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 9.15455367 |
| 2 | Alcoholism_Homo sapiens_hsa05034 | 5.40889297 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.32745975 |
| 4 | Viral carcinogenesis_Homo sapiens_hsa05203 | 2.92693174 |
| 5 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.08258306 |
| 6 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.87480546 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.86467466 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 1.68166408 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 1.52354310 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.51199954 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46130148 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45474483 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43250132 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.42919709 |
| 15 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.42614493 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35010566 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21492804 |
| 18 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.18848776 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15391026 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15370020 |
| 21 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13146750 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09733278 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08096843 |
| 24 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05097690 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.03792893 |
| 26 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95410810 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87421128 |
| 28 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86024431 |
| 29 | Measles_Homo sapiens_hsa05162 | 0.82565559 |
| 30 | Ribosome_Homo sapiens_hsa03010 | 0.82266540 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79892572 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79103547 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78411860 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75514643 |
| 35 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74425267 |
| 36 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74011255 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73201544 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 0.72689240 |
| 39 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71385354 |
| 40 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71180406 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69961168 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.69387961 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66175965 |
| 44 | Malaria_Homo sapiens_hsa05144 | 0.61810054 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59552374 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57354812 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57173302 |
| 48 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55352670 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55266167 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54720556 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54041919 |
| 52 | DNA replication_Homo sapiens_hsa03030 | 0.52888144 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.52465545 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51819597 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51153055 |
| 56 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.50868405 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.50514040 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48729032 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48059209 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47756155 |
| 61 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47681433 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47582257 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47491634 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46310842 |
| 65 | Mismatch repair_Homo sapiens_hsa03430 | 0.44790169 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.44769033 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44656868 |
| 68 | Glioma_Homo sapiens_hsa05214 | 0.44132732 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 0.43254355 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41648550 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40233086 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38680284 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.38334773 |
| 74 | Allograft rejection_Homo sapiens_hsa05330 | 0.37867564 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37191946 |
| 76 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.35930651 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34930256 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34753184 |
| 79 | Cell cycle_Homo sapiens_hsa04110 | 0.33083514 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.32488958 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31786586 |
| 82 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.31519175 |
| 83 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.31201838 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.30896020 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.28728114 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27963856 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.27810592 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.27687718 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.26854733 |
| 90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24352218 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24286817 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.23814511 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.22708429 |
| 94 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.22494028 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22333742 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22234209 |
| 97 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21382794 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.20945220 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.19078341 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.18898732 |

